Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 173

1.

Observational study designs for comparative effectiveness research: an alternative approach to close evidence gaps in head-and-neck cancer.

Goulart BH, Ramsey SD, Parvathaneni U.

Int J Radiat Oncol Biol Phys. 2014 Jan 1;88(1):106-14. doi: 10.1016/j.ijrobp.2013.05.050. Review.

PMID:
24331656
2.

Comparative effectiveness in head and neck malignancies.

Lewis CM, Hutcheson KA, Kupferman ME.

Cancer Treat Res. 2015;164:89-99. doi: 10.1007/978-3-319-12553-4_6.

PMID:
25677020
4.

An overview of methods for comparative effectiveness research.

Meyer AM, Wheeler SB, Weinberger M, Chen RC, Carpenter WR.

Semin Radiat Oncol. 2014 Jan;24(1):5-13. doi: 10.1016/j.semradonc.2013.09.002. Review.

PMID:
24314337
5.

Some methodological points to consider when performing systematic reviews in comparative effectiveness research.

Berlin JA, Cepeda MS.

Clin Trials. 2012 Feb;9(1):27-34. doi: 10.1177/1740774511427062. Epub 2011 Nov 2.

PMID:
22049086
6.

The effect of financial incentives on the quality of health care provided by primary care physicians.

Scott A, Sivey P, Ait Ouakrim D, Willenberg L, Naccarella L, Furler J, Young D.

Cochrane Database Syst Rev. 2011 Sep 7;(9):CD008451. doi: 10.1002/14651858.CD008451.pub2. Review.

PMID:
21901722
7.

Generating evidence for comparative effectiveness research using more pragmatic randomized controlled trials.

Mullins CD, Whicher D, Reese ES, Tunis S.

Pharmacoeconomics. 2010;28(10):969-76. doi: 10.2165/11536160-000000000-00000.

PMID:
20831305
8.

Approaches to answering critical CER questions.

Kinnier CV, Chung JW, Bilimoria KY.

Cancer Treat Res. 2015;164:1-14. doi: 10.1007/978-3-319-12553-4_1.

PMID:
25677015
9.

Review of guidelines for good practice in decision-analytic modelling in health technology assessment.

Philips Z, Ginnelly L, Sculpher M, Claxton K, Golder S, Riemsma R, Woolacoot N, Glanville J.

Health Technol Assess. 2004 Sep;8(36):iii-iv, ix-xi, 1-158. Review.

10.

Observational studies in systematic [corrected] reviews of comparative effectiveness: AHRQ and the Effective Health Care Program.

Norris SL, Atkins D, Bruening W, Fox S, Johnson E, Kane R, Morton SC, Oremus M, Ospina M, Randhawa G, Schoelles K, Shekelle P, Viswanathan M.

J Clin Epidemiol. 2011 Nov;64(11):1178-86. doi: 10.1016/j.jclinepi.2010.04.027. Epub 2011 Jun 1. Erratum in: J Clin Epidemiol. 2013 Oct;66(10):1194.

PMID:
21636246
11.

The role for pragmatic randomized controlled trials (pRCTs) in comparative effectiveness research.

Chalkidou K, Tunis S, Whicher D, Fowler R, Zwarenstein M.

Clin Trials. 2012 Aug;9(4):436-46. doi: 10.1177/1740774512450097. Epub 2012 Jul 2.

PMID:
22752634
12.

Interventions for the prevention and management of oropharyngeal candidiasis associated with HIV infection in adults and children.

Pienaar ED, Young T, Holmes H.

Cochrane Database Syst Rev. 2010 Nov 10;(11):CD003940. doi: 10.1002/14651858.CD003940.pub3. Review.

PMID:
21069679
13.

The methods of comparative effectiveness research.

Sox HC, Goodman SN.

Annu Rev Public Health. 2012 Apr;33:425-45. doi: 10.1146/annurev-publhealth-031811-124610. Epub 2012 Jan 3. Review.

PMID:
22224891
14.

Methods for the comparative evaluation of pharmaceuticals.

Zentner A, Velasco-Garrido M, Busse R.

GMS Health Technol Assess. 2005 Nov 15;1:Doc09.

15.

Bone graft substitutes for the treatment of traumatic fractures of the extremities.

Hagen A, Gorenoi V, Schönermark MP.

GMS Health Technol Assess. 2012;8:Doc04. doi: 10.3205/hta000102. Epub 2012 Jun 14.

16.

The role of observational investigations in comparative effectiveness research.

Marko NF, Weil RJ.

Value Health. 2010 Dec;13(8):989-97. doi: 10.1111/j.1524-4733.2010.00786.x. Review.

17.

Comparative effectiveness research in oncology methodology: observational data.

Hershman DL, Wright JD.

J Clin Oncol. 2012 Dec 1;30(34):4215-22. doi: 10.1200/JCO.2012.41.6701. Epub 2012 Oct 15. Review.

PMID:
23071228
18.

Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation.

Main C, Bojke L, Griffin S, Norman G, Barbieri M, Mather L, Stark D, Palmer S, Riemsma R.

Health Technol Assess. 2006 Mar;10(9):1-132. iii-iv. Review.

19.

Newer hypnotic drugs for the short-term management of insomnia: a systematic review and economic evaluation.

D√ľndar Y, Boland A, Strobl J, Dodd S, Haycox A, Bagust A, Bogg J, Dickson R, Walley T.

Health Technol Assess. 2004 Jun;8(24):iii-x, 1-125. Review.

20.

Over-, under- and misuse of pain treatment in Germany.

Dietl M, Korczak D.

GMS Health Technol Assess. 2011 Apr 19;7:Doc03. doi: 10.3205/hta000094.

Supplemental Content

Support Center